Saturday, February 14, 2015 5:39:24 PM
10Q filed May 14, 2014
Page 10
On May 8, 2014, the Company signed a joint venture agreement with Cenco Leasing LLC. (Cenco) The agreement calls for a joint venture to be formed between the Company and Cenco for the purpose of funding a GETH facility in Stockton, CA with Cenco funding the project. The Company will own 30% (thirty percent) of the joint venture and Cenco will own 70%. The agreement also calls for Cenco to provide two one year 8% loans to the Company with stock conversion rights. The first loan will be $50,000 (fifty thousand) due when the agreement is signed and the second loan in the amount of $40,000 (forty thousand) is due on June 2, 2014.
-10-
Page 11
On May 8, 2014, the Company signed an agreement with Cenco Leasing LLC (“Cenco”) The agreement calls for a joint venture to be formed between the Company and Cenco for the purpose of funding a GETH facility in Stockton, CA with Cenco funding the project. The Company will own 30% (thirty percent) of the joint venture and Cenco will own 70%. The agreement also calls for Cenco to provide two one year 8% loans to the Company with stock conversion rights. Funding for the first loan will be $50,000 and provided when the definitive joint venture agreement is signed and funding for the second loan for the amount of $40,000 shall be provided on June 2, 2014.
-11-
10Q filed Aug 14, 2014
Page 11
On May 8, 2014, the Company signed a memorandum of understanding with Cenco Leasing LLC (“Cenco”), in which the memorandum calls for a joint venture to be formed between the Company and Cenco for the purpose of funding a GETH facility in Stockton, CA with Cenco funding the project. The Company will own 30% (thirty percent) of the joint venture and Cenco will own 70%. The memorandum also calls for Cenco to provide two one year 8% loans to the Company with stock conversion rights. Cenco provided to the Company a loan in the amount of $50,000 on May 8, 2014 and Cenco provided a second loan in the amount of $40,000 on June 2, 2014. As of June 30, 2014, a formal joint venture between the Company and Cenco has not been consummated.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM